FDA found Salmonella Havana in Sabra ready-to-eat hummus and cited preventive-control and sanitation failures at its Virginia plant.
What happened
FDA collected a retail sample of Sabra Classic Hummus that tested positive for Salmonella Havana, and Sabra recalled the product after FDA notified it on March 26, 2021. FDA and Virginia inspectors then inspected the South Chesterfield, Virginia hummus plant from April 28 through May 6, 2021 and found serious violations of the CGMP & PC rule (current good manufacturing practice and preventive-controls rule), including unclear hazard controls for tahini and environmental pathogens, inadequate environmental-monitoring corrective actions, and incomplete corrective actions after the recall.
What FDA found
The hazard analysis did not clearly show whether Salmonella in tahini required a preventive control, including a supply-chain control.
21 CFR 117.130(a)(1); 21 CFR 117.405(a)(1)The hazard analysis did not identify environmental pathogens at the filling steps as hazards requiring sanitation preventive controls.
21 CFR 117.130(c)(ii)Environmental monitoring lacked written corrective-action records for 11 finished-product tests above the threshold and for Listeria-positive swabs, including blank management reviews and no retest records.
21 CFR 117.165(b); 21 CFR 117.150(a)(1)After the Salmonella recall, Sabra did not complete required corrective actions or reanalyze its food safety plan; only 2 of 16 corrections were complete at inspection close.
21 CFR 117.150(b)(1)(ii); 21 CFR 117.150(b)(2)The supply-chain program was inadequate because the third-party audit of the tahini supplier covered peanuts, not tahini or the sesame-seed toasting step that controls Salmonella.
21 CFR 117.405(a)(1); 21 CFR 117.435(b)Employees mishandled equipment used to unload ready-to-eat tahini from bulk totes under conditions that did not minimize contamination.
21 CFR 117.80(c)(2)
What FDA wants
FDA tells Sabra to correct the cited deviations, conduct an in-depth analysis of all aspects of its food safety plan, and take robust corrective action for unanticipated food safety problems. The letter says FDA will verify the adequacy of corrective actions at the next inspection and does not state a response deadline in the excerpt.
Who should pay attention
- brands that buy ready-to-eat foods from contract manufacturers
- hummus and dip makers with ready-to-eat filling steps
- quality teams managing tahini or sesame suppliers
This is a summary. Read the original letter on fda.gov.